BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20651241)

  • 1. Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis.
    Zhang Z; Wang H; Ikeda S; Fahey F; Bielenberg D; Smits P; Hauschka PV
    Am J Pathol; 2010 Sep; 177(3):1459-69. PubMed ID: 20651241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
    Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
    J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer metastasis to the bone: mechanisms of bone loss.
    Chen YC; Sosnoski DM; Mastro AM
    Breast Cancer Res; 2010; 12(6):215. PubMed ID: 21176175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis.
    Marino S; Bishop RT; Logan JG; Mollat P; Idris AI
    Cancer Lett; 2017 Dec; 410():180-190. PubMed ID: 28965856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice.
    Zong JC; Wang X; Zhou X; Wang C; Chen L; Yin LJ; He BC; Deng ZL
    Oncol Rep; 2016 Feb; 35(2):739-48. PubMed ID: 26573960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.
    Ganguly SS; Hostetter G; Tang L; Frank SB; Saboda K; Mehra R; Wang L; Li X; Keller ET; Miranti CK
    Oncogene; 2020 Jan; 39(1):204-218. PubMed ID: 31467432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.
    Chiovaro F; Martina E; Bottos A; Scherberich A; Hynes NE; Chiquet-Ehrismann R
    Int J Cancer; 2015 Oct; 137(8):1842-54. PubMed ID: 25868708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastases.
    Das S; Tucker JA; Khullar S; Samant RS; Shevde LA
    PLoS One; 2012; 7(3):e34374. PubMed ID: 22479615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoblasts suppress high bone turnover caused by osteolytic breast cancer in-vitro.
    Krawetz R; Wu YE; Rancourt DE; Matyas J
    Exp Cell Res; 2009 Aug; 315(14):2333-42. PubMed ID: 19433087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment.
    Haider MT; Saito H; Zarrer J; Uzhunnumpuram K; Nagarajan S; Kari V; Horn-Glander M; Werner S; Hesse E; Taipaleenmäki H
    Breast Cancer Res; 2020 Apr; 22(1):34. PubMed ID: 32272947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
    Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic Switch.
    Mulcrone PL; Campbell JP; Clément-Demange L; Anbinder AL; Merkel AR; Brekken RA; Sterling JA; Elefteriou F
    J Bone Miner Res; 2017 Jul; 32(7):1442-1454. PubMed ID: 28300321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
    Boucharaba A; Serre CM; Grès S; Saulnier-Blache JS; Bordet JC; Guglielmi J; Clézardin P; Peyruchaud O
    J Clin Invest; 2004 Dec; 114(12):1714-25. PubMed ID: 15599396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis.
    Caley MP; Kogianni G; Adamarek A; Gronau JH; Rodriguez-Teja M; Fonseca AV; Mauri F; Sandison A; Rhim JS; Pchejetski D; Palmieri C; Cobb JP; Waxman J; Sturge J
    J Pathol; 2012 Apr; 226(5):775-83. PubMed ID: 22072289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases.
    Bu G; Lu W; Liu CC; Selander K; Yoneda T; Hall C; Keller ET; Li Y
    Int J Cancer; 2008 Sep; 123(5):1034-42. PubMed ID: 18546262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
    Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
    J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis.
    Ohshiba T; Miyaura C; Ito A
    Biochem Biophys Res Commun; 2003 Jan; 300(4):957-64. PubMed ID: 12559967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.
    Nannuru KC; Futakuchi M; Varney ML; Vincent TM; Marcusson EG; Singh RK
    Cancer Res; 2010 May; 70(9):3494-504. PubMed ID: 20406980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone.
    Biswas S; Nyman JS; Alvarez J; Chakrabarti A; Ayres A; Sterling J; Edwards J; Rana T; Johnson R; Perrien DS; Lonning S; Shyr Y; Matrisian LM; Mundy GR
    PLoS One; 2011; 6(11):e27090. PubMed ID: 22096521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation.
    Pan T; Lin SC; Yu KJ; Yu G; Song JH; Lewis VO; Bird JE; Moon B; Lin PP; Tannir NM; Jonasch E; Wood CG; Gallick GE; Yu-Lee LY; Lin SH; Satcher RL
    Neoplasia; 2018 Jan; 20(1):32-43. PubMed ID: 29190493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.